Valuation: Ipca Laboratories Limited

Capitalization 36TCr 396.73Cr 335.83Cr 307.79Cr 291.51Cr 541.29Cr 565.93Cr 3.58TCr 1.42TCr 17TCr 1.49TCr 1.46TCr 62TCr P/E ratio 2026 *
32.1x
P/E ratio 2027 * 26.4x
Enterprise value 37TCr 413.59Cr 350.1Cr 320.88Cr 303.9Cr 564.3Cr 589.99Cr 3.73TCr 1.48TCr 18TCr 1.55TCr 1.52TCr 65TCr EV / Sales 2026 *
3.82x
EV / Sales 2027 * 3.36x
Free-Float
52.38%
Yield 2026 *
0.37%
Yield 2027 * 0.42%
More valuation ratios * Estimated data
Dynamic Chart
1 day+2.49%
1 week+0.84%
Current month-1.28%
1 month-7.81%
3 months+7.97%
6 months+8.63%
Current year+2.33%
More quotes
1 week 1,392.3
Extreme 1392.3
1,470
1 month 1,391.8
Extreme 1391.8
1,574
Current year 1,391.8
Extreme 1391.8
1,582.6
1 year 1,168.2
Extreme 1168.2
1,595
3 years 669.8
Extreme 669.8
1,755.9
5 years 669.8
Extreme 669.8
1,755.9
10 years 200
Extreme 200
1,755.9
More quotes
Manager TitleAgeSince
Chief Executive Officer 53 01/04/2023
Chief Executive Officer 70 01/04/2023
Chief Tech/Sci/R&D Officer 52 16/10/2023
Director TitleAgeSince
Chairman 79 05/07/2012
Director/Board Member 53 11/11/2008
Director/Board Member 70 01/08/1994
More insiders
Change 5d. change 1-year change 3-years change Capi.($)
+2.49%+0.84%+0.28%+65.62% 396.73Cr
+4.48%+2.03%+20.48%+210.56% 95TCr
-0.26%+5.61%+56.73%+46.68% 58TCr
-0.27%+0.19%+17.22%+54.51% 39TCr
-0.32%+0.31%+22.37%+24.95% 37TCr
-1.64%+10.57%+39.70%+14.34% 30TCr
-0.72%-0.01%+19.80%+25.45% 30TCr
+0.67%+2.75%+24.26%+50.41% 30TCr
+7.28%-15.48%-48.77%-34.79% 21TCr
-1.36%+12.41%+30.93%+60.00% 21TCr
Average +0.92%+1.71%+18.30%+51.77% 36.01TCr
Weighted average by Cap. +1.16%+2.75%+24.59%+80.36%
See all sector performances

Financials

2026 *2027 *
Net sales 9.81TCr 108.24Cr 92Cr 84Cr 80Cr 147.68Cr 154.4Cr 975.87Cr 386.33Cr 4.72TCr 405.92Cr 397.57Cr 17TCr 11TCr 120.8Cr 102.26Cr 94Cr 89Cr 164.82Cr 172.32Cr 1.09TCr 431.17Cr 5.27TCr 453.04Cr 443.71Cr 19TCr
Net income 1.11TCr 12Cr 10Cr 9.51Cr 9.01Cr 17Cr 17Cr 110.55Cr 44Cr 534.76Cr 46Cr 45Cr 1.93TCr 1.38TCr 15Cr 13Cr 12Cr 11Cr 21Cr 22Cr 137.15Cr 54Cr 663.46Cr 57Cr 56Cr 2.39TCr
Net Debt 1.53TCr 17Cr 14Cr 13Cr 12Cr 23Cr 24Cr 152.03Cr 60Cr 735.44Cr 63Cr 62Cr 2.65TCr 873.7Cr 9.64Cr 8.16Cr 7.48Cr 7.09Cr 13Cr 14Cr 87Cr 34Cr 420.61Cr 36Cr 35Cr 1.51TCr
More financial data * Estimated data
Logo Ipca Laboratories Limited
Ipca Laboratories Limited is an India-based integrated pharmaceutical company. The Company is manufacturing and marketing over 350 formulations and approximately 80 active pharmaceutical ingredients (APIs) covering various therapeutic segments. It offers APIs, such as Atenolol, Chloroquine Phosphate, Chlorthalidone, Furosemide, Hydroxychloroquine sulfate, Losartan, Metoprolol Succinate, Metoprolol Tartrate, Pyrantel Salts and Propranolol. The Company offers brands, such as Zerodol, Lariago, HCQS, Perinorm, Rapither AB, Tenoric, Lumerax, Etova, Fexova, Malirid, Allsuth, Alwiz, AZR 50mg, Bacilon, Cinkona, Clarbact, Glyree MV, Halotop, Luliz, Ozepam, Pacimol, Pari, Xtor-F, Zabpro, Zilast, Ramcor, Sove, Venpower and Folitrax. The products of the Company are sold in over 100 countries across the globe. The Company has 18 manufacturing units in India manufacturing API’s and formulations. Its subsidiaries include Ipca Pharmaceuticals, Inc., Ipca Pharma Nigeria Ltd., Trophic Wellness Pvt. Ltd.
Employees
16,778
More about the company
Date Price Change Volume
09/26/09 1,452.00 +2.49% 1,11,733
06/26/06 1,416.70 -1.77% 1,10,797
05/26/05 1,442.20 +2.55% 1,93,684
04/26/04 1,406.40 -2.01% 1,17,017
03/26/03 1,435.30 -0.32% 2,07,460

Delayed Quote NSE India S.E., February 09, 2026 at 04:35 pm IST

More quotes
Trader
Investor
Global
Quality
ESG MSCI
BB
More Ratings
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
17
Last Close Price
1,416.70INR
Average target price
1,564.83INR
Spread / Average Target
+10.46%
Consensus

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Equities
  3. IPCALAB Stock